iGMDRD401
| Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
|---|---|---|---|---|---|
| Afatinib | CHEMBL2105712 CHEMBL1173655 | 10184700 | DB08916 | Alone | Small Molecule |
Drug Class:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 InhibitorsBCRP/ABCG2 SubstratesHeterocyclic CompoundsHeterocyclic Compounds, 2-RingKinase InhibitorP-glycoprotein/ABCB1 InhibitorsP-glycoprotein/ABCB1 SubstratesProtein Kinase InhibitorsDrug Pathways:
EGFR signalingDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
| Gene ID | Gene Name | Model Num. |
|---|---|---|
| 7514 | XPO1 | 1 |
| 3845 | KRAS | 5 |
| 8289 | ARID1A | 2 |
| 4771 | NF2 | 3 |
| 2195 | FAT1 | 1 |
| 5175 | PECAM1 | 1 |
| 1111 | CHEK1 | 1 |
| 5605 | MAP2K2 | 1 |
| 7158 | TP53BP1 | 2 |
| 55294 | FBXW7 | 2 |
| 25937 | WWTR1 | 1 |
| 7428 | VHL | 2 |
| 2064 | ERBB2 | 31 |
| 983 | CDK1 | 1 |
| 6850 | SYK | 1 |
| 472 | ATM | 2 |
| 10413 | YAP1 | 1 |
| 1029 | CDKN2A | 1 |
| 7157 | TP53 | 1 |
| 4088 | SMAD3 | 1 |
| 3673 | ITGA2 | 1 |
| 6714 | SRC | 1 |
| 3791 | KDR | 1 |
| 4436 | MSH2 | 1 |
| 57111 | RAB25 | 2 |
| 4089 | SMAD4 | 4 |
| 54658 | UGT1A1 | 1 |
| 5290 | PIK3CA | 2 |
| 675 | BRCA2 | 1 |
| 1956 | EGFR | 206 |
| 4609 | MYC | 1 |
| 5747 | PTK2 | 1 |
| 673 | BRAF | 4 |
| 1938 | EEF2 | 1 |
| 5728 | PTEN | 2 |
| 8821 | INPP4B | 1 |
| 2067 | ERCC1 | 1 |
| 9223 | MAGI1 | 2 |
| 2194 | FASN | 1 |
| 5111 | PCNA | 1 |
| 3717 | JAK2 | 1 |
| 100862685 | ERVK-19 | 1 |
| 5894 | RAF1 | 1 |
| 4893 | NRAS | 1 |
| 2065 | ERBB3 | 17 |
| 374 | AREG | 1 |
| 595 | CCND1 | 1 |
| 4763 | NF1 | 1 |
| 3265 | HRAS | 1 |
| 1499 | CTNNB1 | 1 |
| 5624 | PROC | 1 |
Gene in drug-gene network: Network Plot
Models in Afatinib

